USFDA Approval: Alembic Pharma’s Proven $110M Otic Solution
USFDA approval Alembic Pharma brings a new $110M otic suspension to market, ensuring safe treatment options.
Exploring the Unseen and Unheard
USFDA approval Alembic Pharma brings a new $110M otic suspension to market, ensuring safe treatment options.
DCGI approval colchicine tablets brings new hope for patients seeking effective treatment options.
Drug approval influence is under scrutiny as Democratic Party’s Choi Jae-sung faces accusations of misconduct.